MedPath

PHASE II STUDY OF METRONOMIC ORAL VINORELBINE IN ADVANCED BREASTCANCER - ND

Conditions
Advanced breast cancer
MedDRA version: 9.1Level: LLTClassification code 10057654Term: Breast cancer female
Registration Number
EUCTR2007-002588-28-IT
Lead Sponsor
ISTITUTO EUROPEO DI ONCOLOGIA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Histologically or cytologically proven diagnosis breast cancer with evidence of 1) unresectable, locally recurrent, or 2) metastatic disease. At least one bidimensionally measurable lesion adequately measured by imaging procedure (See section 15). Prior chemotherapy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patient with T4d disease inflammatory cancer as unique disease, symptomatic lung lymphangitis.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath